• Study on Stopping Atorvastatin in Frail Patients Aged 70+ with Recent Ischemic Stroke or Transient Ischemic Attack

    Not yet recruiting

    3 1 1 1
    Investigated drugs:
    The Netherlands
  • Study on Acetazolamide with Radiochemotherapy or Radioimmunotherapy for Patients with Small Cell Lung Cancer

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    France
  • Study on Switching from Dulaglutide to Tirzepatide for Adults with Type 2 Diabetes

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Belgium France Germany Romania
  • Study of Ivosidenib for Patients with Previously Treated Advanced or Metastatic Cholangiocarcinoma

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Germany The Netherlands Sweden
  • Study on BIIB080 for Patients Aged 50-80 with Mild Cognitive Impairment or Mild Alzheimer’s Disease Dementia

    Not yet recruiting

    2 1 1
    Investigated diseases:
    Belgium Czechia Denmark Finland France Germany +5
  • Study on the Safety and Effectiveness of GFH925 and Cetuximab for Patients with Advanced Lung Cancer with KRAS G12C Mutation

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    France Greece Italy Spain
  • Study of Peresolimab for Adults with Moderate to Severe Rheumatoid Arthritis

    Not yet recruiting

    2 1 1
    Investigated diseases:
    Greece Hungary Italy Poland Spain
  • Study Comparing MK-7684A (Vibostolimab and Pembrolizumab) with Pembrolizumab for Adults and Children with High-Risk Melanoma

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Austria Belgium France Germany Ireland Italy +3
  • Study on Atorvastatin for Preventing Episodic Migraine in Adults

    Not yet recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Norway
  • Study on Atorvastatin for Preventing Chronic Migraine in Adults

    Not yet recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Norway

powered by